Rush E. Simonson, CEO and Chairman
Mr. Simonson has been involved in finance and healthcare for over 20 years. He served as VP of First National Bank of Palm Beach and was a co-founding general partner (G&S Capital) in two successful convertible hedge funds. His partner, Kenneth Griffin, went on to found Citadel, LLC. Mr. Simonson became well known in the spinal industry following the founding of a medical distributorship for Medtronic, Inc. that was acquired by Medtronic. He is an inventor and holds 3 pioneer patents for posterior lumbar spinal artificial disks and has experience developing biomedical intellectual property. He was founding CEO and Director of Cytonics Corporation (“Cytonics”), a proteomics discovery start-up. During his tenure at Cytonics, he led a national team of scientists from Stanford University and the University of Pittsburgh, to discover the novel protein complex believed to be responsible for back and joint pain. Mr. Simonson initiated partnership discussions that recently resulted in a 20% acquisition by Synthes/J&J. He graduated from Florida Atlantic University with a BBA (Entrepreneurial Studies and Finance). Has also completed advanced management development program at Harvard’s Kennedy School and is well versed in the fields of protein discovery, stem-cell and regenerative medicine, medical expert, and IT systems.
Peter M. Simonson, President and Board Member
With 20 years of executive experience in sales, marketing, management, product development, engineering, business development, market research and consulting, Mr. Simonson holds a Mechanical Engineering degree from Georgia Tech.
He has been awarded five patents for surgical products, with an additional seven patents pending. He is the inventor of the Medtronic’s patented unique spinal implant a system, TSRH-3D®, which has sold in excess of $1 billion in more the 30 countries. Mr. Simonson and the team developing his technology received Medtronic’s global Technical-Contributor-of-The-Year award. Mr. Simonson has become highly sought after worldwide for his talents as a sales trainer and motivational speaker. After proving his skills invaluable in more than 60 markets, Medtronic now features his pioneering sales techniques in sales training videos and curriculum worldwide.
J.R. Slaughter, Advisor*
20-year sales and management career as medical device executive working with companies Medtronic and President of Bluegrass Spine 2007-2012, a Stryker distributorship. He also founded and built a very successful, award-winning, horse racing stable, Slaughter Racing Stables. Before assuming the position of Vice President for RTC, Mr. Slaughter served as Director of RTC’s Aging Care Division and is also a graduate of Franklin University.
Patsy Trisler, Regulatory Consultant, and Juvent Founding Member*
Ms. Trisler has served as our regulatory affairs consultant since inception. She has over 20 years’ experience in FDA regulatory affairs and has been a consultant to the medical device industry since 1991, serving as the external regulatory affairs resource to many start-up companies with an expertise in strategic planning related to regulated-product pathway, FDA submissions, requirements for pre-clinical and clinical testing and post-approval requirements, including compliance with GMPs under the Quality System Regulations. From 1998 to 2003, Ms. Trisler was employed by multi-national clinical contract research organizations (CRO), where, in addition to direct consulting with medical device clients, she provided regulatory support to assure compliance with Good Clinical Practices. Ms. Trisler provided regulatory assistance to Exogen prior to its acquisition by S&N and since has been the external consultant to S&N on regulatory matters related to the Exogen product line where she provided assistance on FDA matters pertaining to the MST technology. From 1985 to 1991, Ms. Trisler was on the staff at the FDA’s Center for Devices and Radiological Health where she was the lead scientific reviewer for electrical, electromagnetic and ultrasound bone growth stimulator devices. Prior to working at the FDA, Ms. Trisler was a laboratory technician at the NIH’s National Cancer Institute. Her undergraduate degree is in Biology from the American University, and she earned the J.D. degree from Potomac Law School. She is also a certified regulatory affairs professional.
Craig Kennedy, Vice President of Intellectual Property*
Technology Transfer Officer at University of California, Los Angeles and was formerly a Technology Licensing Officer at Massachusetts Institute of Technology (MIT) in the area of Biotechnology. Craig also works as an intellectual property advisor to a number of biotechnology companies and has specific expertise in medical device and biomarkers.